Standout Papers

Decitabine improves patient outcomes in myelodysplastic syndromes 2000 2026 2008 2017 1.1k
  1. Decitabine improves patient outcomes in myelodysplastic syndromes (2006)
    Hagop M. Kantarjian, Jean‐Pierre J. Issa et al. Cancer
  2. Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412 (2004)
    Richard M. Stone, Daniel J. DeAngelo et al. Blood
  3. Report of an international working group to standardize response criteria for myelodysplastic syndromes. (2000)
    Bruce D. Cheson, John M. Bennett et al. PubMed

Immediate Impact

10 by Nobel laureates 16 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
2021 Standout
Spermidine in health and disease
2018 StandoutScience
6 intermediate papers

Works of Stephen D. Nimer being referenced

Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
2016
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
2004
and 2 more

Author Peers

Author Last Decade Papers Cites
Stephen D. Nimer 6656 7352 3321 238 14.3k
Tomoki Naoe 7781 8020 2834 350 15.5k
Kevin Shannon 3699 6088 2200 274 12.3k
Raymond Alexanian 10334 6972 5901 225 14.1k
Hervé Avet‐Loiseau 11908 10704 6969 373 16.2k
Brigitte Schlegelberger 6549 7663 2898 393 16.0k
Sylvie Castaigné 5857 4981 2029 165 9.0k
Dolors Colomer 2665 5039 3036 277 11.7k
Régis Bataille 9854 8430 7418 266 16.7k
Yuzuru Kanakura 4640 4602 3335 366 16.2k
Bruno Calabretta 3378 8578 2621 237 13.1k

All Works

Loading papers...

Rankless by CCL
2026